Goldman Sachs’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $49.4M | Buy |
354,500
+339,800
| +2,312% | +$47.6M | 0.01% | 1582 |
|
|
2025
Q4 | $1.8M | Buy |
14,700
+700
| +5% | +$85.1K | ﹤0.01% | 4690 |
|
|
2025
Q3 | $1.55M | Buy |
14,000
+5,000
| +56% | +$568K | ﹤0.01% | 4694 |
|
|
2025
Q2 | $998K | Buy |
9,000
+1,000
| +13% | +$106K | ﹤0.01% | 4706 |
|
|
2025
Q1 | $896K | Sell |
8,000
-34,600
| -81% | -$3.57M | ﹤0.01% | 4766 |
|
|
2024
Q4 | $3.93M | Hold |
42,600
| – | – | ﹤0.01% | 3690 |
|
|
2024
Q3 | $3.57M | Sell |
42,600
-15,000
| -26% | -$1.14M | ﹤0.01% | 3651 |
|
|
2024
Q2 | $3.95M | Hold |
57,600
| – | – | ﹤0.01% | 3379 |
|
|
2024
Q1 | $4.22M | Sell |
57,600
-20,800
| -27% | -$1.6M | ﹤0.01% | 3251 |
|
|
2023
Q4 | $6.35M | Sell |
78,400
-14,900
| -16% | -$1.16M | ﹤0.01% | 2961 |
|
|
2023
Q3 | $6.99M | Sell |
93,300
-30,400
| -25% | -$2.34M | ﹤0.01% | 2700 |
|
|
2023
Q2 | $9.53M | Sell |
123,700
-56,100
| -31% | -$4.47M | ﹤0.01% | 2502 |
|
|
2023
Q1 | $14.9M | Buy |
179,800
+50,200
| +39% | +$4.16M | ﹤0.01% | 2066 |
|
|
2022
Q4 | $11.1M | Buy |
129,600
+99,500
| +331% | +$7.88M | ﹤0.01% | 2482 |
|
|
2022
Q3 | $1.86M | Sell |
30,100
-103,500
| -77% | -$6.53M | ﹤0.01% | 4045 |
|
|
2022
Q2 | $8.26M | Sell |
133,600
-51,000
| -28% | -$3.16M | ﹤0.01% | 2686 |
|
|
2022
Q1 | $11M | Sell |
184,600
-11,900
| -6% | -$761K | ﹤0.01% | 2595 |
|
|
2021
Q4 | $14.3M | Buy |
196,500
+10,900
| +6% | +$751K | ﹤0.01% | 2434 |
|
|
2021
Q3 | $13M | Sell |
185,600
-719,900
| -80% | -$50.6M | ﹤0.01% | 2462 |
|
|
2021
Q2 | $62.4M | Buy |
905,500
+366,900
| +68% | +$24.5M | 0.01% | 1078 |
|
|
2021
Q1 | $34.8M | Sell |
538,600
-146,000
| -21% | -$9.41M | 0.01% | 1462 |
|
|
2020
Q4 | $39.9M | Sell |
684,600
-17,500
| -2% | -$1.06M | 0.01% | 1303 |
|
|
2020
Q3 | $44.4M | Buy |
702,100
+270,300
| +63% | +$18.7M | 0.01% | 1093 |
|
|
2020
Q2 | $33.2M | Buy |
431,800
+135,300
| +46% | +$10.4M | 0.01% | 1281 |
|
|
2020
Q1 | $22.2M | Sell |
296,500
-7,600
| -2% | -$525K | 0.01% | 1428 |
|
|
2019
Q4 | $19.8M | Sell |
304,100
-230,100
| -43% | -$15M | 0.01% | 1877 |
|
|
2019
Q3 | $33.9M | Sell |
534,200
-140,500
| -21% | -$9.18M | 0.01% | 1385 |
|
|
2019
Q2 | $45.6M | Buy |
674,700
+114,100
| +20% | +$7.51M | 0.01% | 1198 |
|
|
2019
Q1 | $36.4M | Buy |
560,600
+267,000
| +91% | +$17.7M | 0.01% | 1373 |
|
|
2018
Q4 | $18.4M | Buy |
293,600
+84,200
| +40% | +$5.89M | 0.01% | 1867 |
|
|
2018
Q3 | $16.2M | Sell |
209,400
-419,100
| -67% | -$31.7M | ﹤0.01% | 2083 |
|
|
2018
Q2 | $44.5M | Buy |
628,500
+44,600
| +8% | +$3.15M | 0.01% | 1294 |
|
|
2018
Q1 | $44M | Sell |
583,900
-408,200
| -41% | -$32.4M | 0.01% | 1284 |
|
|
2017
Q4 | $71.1M | Sell |
992,100
-332,400
| -25% | -$25.2M | 0.02% | 1030 |
|
|
2017
Q3 | $107M | Buy |
1,324,500
+104,500
| +9% | +$7.99M | 0.03% | 770 |
|
|
2017
Q2 | $86.4M | Buy |
1,220,000
+7,400
| +0.6% | +$492K | 0.02% | 867 |
|
|
2017
Q1 | $82.4M | Sell |
1,212,600
-1,028,800
| -46% | -$72.3M | 0.02% | 886 |
|
|
2016
Q4 | $161M | Buy |
2,241,400
+817,000
| +57% | +$60.7M | 0.05% | 490 |
|
|
2016
Q3 | $113M | Sell |
1,424,400
-500
| -0% | -$40.6K | 0.03% | 647 |
|
|
2016
Q2 | $119M | Buy |
1,424,900
+235,300
| +20% | +$20.9M | 0.04% | 568 |
|
|
2016
Q1 | $109M | Sell |
1,189,600
-430,900
| -27% | -$38.9M | 0.04% | 616 |
|
|
2015
Q4 | $164M | Sell |
1,620,500
-575,800
| -26% | -$59.9M | 0.05% | 435 |
|
|
2015
Q3 | $216M | Buy |
2,196,300
+728,000
| +50% | +$80.9M | 0.07% | 286 |
|
|
2015
Q2 | $172M | Sell |
1,468,300
-27,800
| -2% | -$3.04M | 0.05% | 399 |
|
|
2015
Q1 | $147M | Buy |
1,496,100
+247,500
| +20% | +$25.1M | 0.05% | 477 |
|
|
2014
Q4 | $118M | Buy |
1,248,600
+317,500
| +34% | +$32.8M | 0.04% | 589 |
|
|
2014
Q3 | $99.1M | Buy |
931,100
+226,800
| +32% | +$22.2M | 0.03% | 648 |
|
|
2014
Q2 | $58.4M | Sell |
704,300
-974,000
| -58% | -$75.8M | 0.02% | 980 |
|
|
2014
Q1 | $119M | Buy |
1,678,300
+536,600
| +47% | +$42.1M | 0.04% | 545 |
|
|
2013
Q4 | $85.7M | Buy |
1,141,700
+83,700
| +8% | +$5.83M | 0.03% | 699 |
|
|
2013
Q3 | $66.5M | Buy |
1,058,000
+205,700
| +24% | +$12.3M | 0.02% | 797 |
|
|
2013
Q2 | $43.7M | Buy |
+852,300
| New | +$44.4M | 0.02% | 986 |
|
Other funds holding GILD
VCM
VPM
Goldman Sachs's GILD Position: Q1 2026 in Review
Goldman Sachs increased its Gilead Sciences (GILD) stake by 26% in Q1 2026, buying an estimated $324M and bringing the position to 11,065,214 shares worth $1.54B. The position accounts for 0.18% of the portfolio, ranked #93.
Goldman Sachs first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.35B in Q2 2014. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Goldman Sachs held 11,065,214 shares of Gilead Sciences worth $1.54B as of Q1 2026.
- Goldman Sachs bought 2,312,701 Gilead Sciences shares in Q1 2026, an estimated $324M.
- Gilead Sciences made up 0.18% of Goldman Sachs's portfolio in Q1 2026, its #93 holding.
- Goldman Sachs first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- Goldman Sachs's Gilead Sciences position peaked at $2.35B in Q2 2014.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.